Jeremy Skillington
Algemeen Directeur bij POOLBEG PHARMA PLC
Vermogen: 131 793 $ op 30-04-2024
Actieve functies van Jeremy Skillington
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
POOLBEG PHARMA PLC | Directeur/Bestuurslid | 01-05-2021 | - |
Algemeen Directeur | 01-05-2021 | - | |
TriMod Therapeutics Ltd.
TriMod Therapeutics Ltd. BiotechnologyHealth Technology TriMod Therapeutics Ltd develops novel platform technologies to treat cancer and autoimmune diseases. It offers TriMoVac technology that enhances the patients' immune response to the tumour and promotes its eradication by attenuating its' immune subversion strategies. The company was founded by Kingston Mills and Jeremy Skillingtonand in 2011 is headquartered in Dublin, Ireland. | Algemeen Directeur | 01-01-2011 | - |
Oprichter | 01-01-2011 | - |
Loopbaan van Jeremy Skillington
Eerdere bekende functies van Jeremy Skillington
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Corporate Officer/Principal | 02-12-2009 | 01-11-2010 |
Academia, Inc.
Academia, Inc. Internet Software/ServicesTechnology Services Academia, Inc. develops and provides social sharing platform for academic researchers. Its platform enables researchers to share their research, monitor deep analytics, and track the research of academics they follow. The company was founded by Richard Price in September 2008 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Opleiding van Jeremy Skillington
National University of Ireland | Doctorate Degree |
Statistieken
Internationaal
Ierland | 4 |
Verenigde Staten | 3 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Technology Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
POOLBEG PHARMA PLC | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
TriMod Therapeutics Ltd.
TriMod Therapeutics Ltd. BiotechnologyHealth Technology TriMod Therapeutics Ltd develops novel platform technologies to treat cancer and autoimmune diseases. It offers TriMoVac technology that enhances the patients' immune response to the tumour and promotes its eradication by attenuating its' immune subversion strategies. The company was founded by Kingston Mills and Jeremy Skillingtonand in 2011 is headquartered in Dublin, Ireland. | Health Technology |
Academia, Inc.
Academia, Inc. Internet Software/ServicesTechnology Services Academia, Inc. develops and provides social sharing platform for academic researchers. Its platform enables researchers to share their research, monitor deep analytics, and track the research of academics they follow. The company was founded by Richard Price in September 2008 and is headquartered in San Francisco, CA. | Technology Services |
- Beurs
- Insiders
- Jeremy Skillington
- Ervaring